Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 165Not yet recruiting 63Active not recruiting 49Completed 33Terminated 11Suspended 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 34Magnetic Resonance Spectroscopy 22Biopsy 20Cyclophosphamide 11venetoclax 7Nivolumab 6Azacitidine 6pembrolizumab 5Etoposide 5Cisplatin 5Bevacizumab 5fludarabine phosphate 4fludarabine 4Vincristine 4Taxes 4Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Radiosurgery 4Radiation 4Doxorubicin 4Cetuximab 4durvalumab 3decitabine and cedazuridine drug combination 3X-Rays 3Tacrolimus 3Surveys and Questionnaires 3Prednisone 3Platinum 3Leucovorin 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Drug Therapy × 1 year × Clear all
NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06728657 2025-06-18

TORCH-G

Fudan University

Phase 2 Suspended
68 enrolled
Gastrointestinal

Stomach Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡